The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
evitria AG, a global antibody expression service provider located in Zurich, Switzerland, has entered into a non-exclusive bYlok® bispecific pairing ...
read more
5 Prime Sciences, a biotechnology data analytics company focused on using human genetics to accelerate drug development, announced a strategic ...
read more
In response to President Biden's Executive Order 14081, "Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure ...
read more
Takeda and AC Immune SA announced an exclusive, worldwide option and license agreement for AC Immune’s active immunotherapies targeting toxic forms of...
read more
As part of Sanofi’s commitment to developing a diverse portfolio of best-in-class vaccines, the company has entered into a co-exclusive licensing ...
read more
Astellas Pharma Inc. announced the opening of a new $90 million, state-of-the-art center at 480 Forbes Boulevard in South San Francisco, CA. The newly...
read more
Merck announced that Health Canada has granted approval of KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with gemcitabine-based...
read more
Bristol Myers Squibb announced that the FDA accepted the Biologics License Application (BLA) for the subcutaneous formulation of Opdivo® (nivolumab) ...
read more
Can-Fite BioPharma Ltd. announced that the FDA granted Investigational New Drug (IND) clearance for Namodenoson, for the treatment of patients with ...
read more
Ligand Pharmaceuticals and Agenus Inc. announced that the companies have entered into a royalty financing agreement to support Agenus’ key development...
read more
mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, is pleased to announce the appointment of Jurgen Van Broeck...
read more
Minaris Regenerative Medicine, a global manufacturing partner to the cell and gene therapy industry, today announced that the first commercial ...
read more
ProQR Therapeutics, a company dedicated to changing lives through transformative RNA therapies, announced new preclinical data for its proprietary ...
read more
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses,...
read more
MetP Pharma AG, leveraging the proprietary nose-to-brain drug delivery technology BrainDos™ in internal and external product development and ...
read more